m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT00602
|
[1], [2], [3], [4], [5], [6] | |||
: m6A sites
Indirect
Enhancement
RNA modification
PTEN
PTEN
TET3
Demethylation
: modification sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Methyltransferase-like 3 (METTL3) | WRITER | |||
| m6A Target | microRNA 21 (MIR21) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | RNA modification (RNAMod) >> 5-methylcytidine (m5C) | ||||
| Epigenetic Regulator | Methylcytosine dioxygenase TET3 (TET3) | ERASER | View Details | ||
| Regulated Target | Mutated in multiple advanced cancers 1 (PTEN) | View Details | |||
| Crosstalk Relationship | m6A → m5C | Enhancement | |||
| Crosstalk Mechanism | m6A modification indirectly impacts RNA modification through downstream signaling pathways | ||||
| Crosstalk Summary | METTL3 interacts with microRNA 21 (MIR21), decreasing its m6A level and promoting its physical interaction with Mutated in multiple advanced cancers 1 (PTEN), which was regulated by TET3-mediated m5C modification. | ||||
In-vitro Model |
Hep 3B2.1-7 | Childhood hepatocellular carcinoma | Homo sapiens | CVCL_0326 | |
| Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 | ||
| HK2 | Normal | Acipenser baerii | CVCL_YE28 | ||
References
: m6A sites
: modification sites